BrainsGate is a medical device company committed to developing innovative therapies for patients suffering from Central Nervous System (CNS) diseases. The company's platform technology involves electrical stimulation of the Spheno-Palatine Ganglion (SPG), a nervous center known to increase cerebral blood flow.
BrainsGate is exploring several applications for its technology, and is currently focusing on two directions: treatment of acute ischemic stroke, and chronic SPG stimulation to treat vascular dementia patients.
BrainsGate is exploring several applications for its technology, and is currently focusing on two directions: treatment of acute ischemic stroke, and chronic SPG stimulation to treat vascular dementia patients.
Location: Israel, Haifa District, Caesarea
Employees: 11-50
Total raised: $14M
Founded date: 2002
Investors 5
| Date | Name | Website |
| - | Cipio Part... | cipiopartn... |
| - | Infinity G... | infinity-e... |
| - | Elron Vent... | elronventu... |
| - | Elron Elec... | elron.com |
| - | Agate Medi... | agate-inve... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 07.12.2020 | Series F | $14M | Cipio Part... |
Mentions in press and media 2
| Date | Title | Description |
| 07.12.2020 | BrainsGate, Ltd. announced that it has received $14 million in funding from Elron Electronic Industries Ltd., Agate Medical Investments, Pitango Venture Capital, Spero Ventures, Medtronic plc, Cipio P... | BrainsGate, Ltd. announced that it has received $14 million in a round of funding led by new investors Spero Ventures and BNP Joint Capital Fund, a fund managed by BNPP Capital Partners on December 7, 2020. The transaction included particip... |
| 06.12.2020 | BrainsGate raises $14 million at $147 million valuation ahead of entering market with stroke treatment system | The Israeli company, which has developed a technology for the treatment of strokes named the Ischemic Stroke System, completed a new funding round led by new investors BNP and SPERO |